- US-listed companies
- ClearPoint Neuro, Inc.
ClearPoint Neuro, Inc.CLPT
Market cap
$298.89M
P/E ratio
| Dec 31, 2012 | Dec 31, 2013 | Dec 31, 2014 | Dec 31, 2015 | Dec 31, 2016 | Dec 31, 2017 | Dec 31, 2018 | Dec 31, 2019 | Dec 31, 2020 | Dec 31, 2021 | Dec 31, 2022 | |
| Product revenue | - | - | - | - | - | - | 7 | 9 | 9 | 12 | 13 |
| Service | - | - | - | - | - | - | 668,246 | 2 | 4 | 4 | 8 |
| Revenues | 5 | 4 | 4 | 5 | 6 | 7 | 7 | 11 | 13 | 16 | 21 |
| Cost of revenue | 555,703 | 1 | 2 | 2 | 3 | 3 | 2 | 4 | 4 | 5 | 7 |
| Gross profit | - | - | - | - | - | - | - | - | - | 11 | 14 |
| Research and development costs | 2 | 3 | 3 | 2 | 3 | 3 | 2 | 3 | 5 | 9 | 11 |
| Sales and marketing expenses | - | - | - | - | - | 4 | 4 | 5 | 5 | 7 | 9 |
| General and administrative expenses | 6 | 7 | 8 | 8 | 8 | 4 | 4 | 4 | 5 | 9 | 10 |
| Operating loss | -3,129,278 | -7,474,771 | -5,320,622 | -8,974,109 | -7,488,738 | -6,335,837 | -5,247,768 | -4,593,678 | -6 | -13 | -16 |
| Other expense, net | 3,586 | 56,228 | 175,547 | 230,875 | 216,075 | 16,682 | 364 | 9,054 | 1 | -0 | -0 |
| Interest expense, net | 3 | 499,839 | 1 | 1 | 1 | 872,926 | 980,383 | 955,166 | 1 | 1 | 0 |
| Net loss | -5,707,136 | -7,086,274 | -4,524,732 | -8,449,246 | -8,069,895 | -7,167,353 | -6,163,469 | -5,539,790 | -7 | -14 | -16 |
| Basic (in usd per share) | - | - | - | - | - | - | - | - | - | - | -0.68 |
| Diluted (in usd per share) | - | - | - | - | - | - | - | - | - | - | -0.68 |